Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Frontiers in Medicine
|
March 21, 2024
The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population-A comparison of two German registries
Rebecca Hasseli, Frank Hanses, Melanie Stecher, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
March 20, 2020
[Frequencies of musculoskeletal symptoms and disorders in the population-based German National Cohort (GNC)]
Carsten Oliver Schmidt, Klaus-Peter Günther, Jens Goronzy, et al.
Medicine
|
August 13, 2015
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study
Lorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè, et al.
Clinical Reviews in Allergy & Immunology
|
January 20, 2016
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group
Lorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè, et al.
The Journal of Rheumatology
|
November 17, 2018
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study
Marco Sebastiani, Konstantinos Triantafyllias, Andreina Manfredi, et al.
Arthritis Research & Therapy
|
May 17, 2011
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
Hans-Peter Tony, Gerd Burmester, Hendrik Schulze-Koops, et al.
Arthritis Care & Research
|
August 29, 2023
Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance Registry
Jinoos Yazdany, Anna Ware, Zachary S Wallace, et al.
Annals of the Rheumatic Diseases
|
February 17, 2022
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance
Manuel Francisco Ugarte-Gil, Graciela S Alarcón, Zara Izadi, et al.
Annals of the Rheumatic Diseases
|
May 29, 2021
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
Jeffrey A Sparks, Zachary S Wallace, Andrea M Seet, et al.
Clinical and Experimental Rheumatology
|
August 4, 2017
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome
Miguel A González-Gay, Carlomaurizio Montecucco, Albert Selva-O'Callaghan, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Frontiers in Medicine
|
March 21, 2024
The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population-A comparison of two German registries
Rebecca Hasseli, Frank Hanses, Melanie Stecher, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
March 20, 2020
[Frequencies of musculoskeletal symptoms and disorders in the population-based German National Cohort (GNC)]
Carsten Oliver Schmidt, Klaus-Peter Günther, Jens Goronzy, et al.
Medicine
|
August 13, 2015
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study
Lorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè, et al.
Clinical Reviews in Allergy & Immunology
|
January 20, 2016
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group
Lorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè, et al.
The Journal of Rheumatology
|
November 17, 2018
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study
Marco Sebastiani, Konstantinos Triantafyllias, Andreina Manfredi, et al.
Arthritis Research & Therapy
|
May 17, 2011
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
Hans-Peter Tony, Gerd Burmester, Hendrik Schulze-Koops, et al.
Arthritis Care & Research
|
August 29, 2023
Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance Registry
Jinoos Yazdany, Anna Ware, Zachary S Wallace, et al.
Annals of the Rheumatic Diseases
|
February 17, 2022
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance
Manuel Francisco Ugarte-Gil, Graciela S Alarcón, Zara Izadi, et al.
Annals of the Rheumatic Diseases
|
May 29, 2021
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
Jeffrey A Sparks, Zachary S Wallace, Andrea M Seet, et al.
Clinical and Experimental Rheumatology
|
August 4, 2017
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome
Miguel A González-Gay, Carlomaurizio Montecucco, Albert Selva-O'Callaghan, et al.
Page
of 8